Probi AB, commonly known as Probi, is a leading player in the probiotics industry, headquartered in Sweden (SE). Founded in 1991, the company has established itself as a pioneer in the development of probiotic products, focusing on health and wellness solutions. Probi operates primarily in Europe and North America, catering to a diverse range of sectors including dietary supplements, functional foods, and beverages. Probi's core offerings include a variety of scientifically validated probiotic strains, which are distinguished by their efficacy and safety. The company has achieved significant milestones, including partnerships with major global brands and recognition for its innovative research in gut health. With a strong market position, Probi continues to drive advancements in the probiotic field, contributing to improved health outcomes worldwide.
How does Probi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Probi's score of 55 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Probi reported total greenhouse gas emissions of approximately 3,600,000 kg CO2e, with emissions distributed across all three scopes: Scope 1 at 1,200,000 kg CO2e, Scope 2 also at 1,200,000 kg CO2e, and Scope 3 at 1,200,000 kg CO2e. Notably, Scope 3 emissions included significant contributions from business travel (about 1,498,000 kg CO2e) and purchased goods and services (approximately 1,450,000 kg CO2e). Probi has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 46% by 2030, using 2019 as the base year. This target has been approved through a streamlined validation route for small and medium-sized enterprises (SMEs) and aligns with the necessary reductions to limit global warming to 1.5°C. The company is also committed to measuring and reducing its Scope 3 emissions, reflecting a comprehensive approach to its climate impact. Overall, Probi's emissions data and reduction targets underscore its commitment to sustainability and climate action, positioning the company as a responsible player in the pharmaceuticals and biotechnology sector.
Access structured emissions data, company-specific emission factors, and source documents
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Scope 1 | 1,908,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000 | 000,000 | 0,000,000 |
Scope 2 | 1,697,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000 | 000,000 | 0,000,000 |
Scope 3 | 245,300 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 0,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Probi is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.